COMPOSITIONS FOR TREATING OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES AND SKIN AGEING

(19)

(11)

EP 3 880 304 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 2 (W2 B1)

(48)	Corrigendum issued on:
	05.03.2025 Bulletin 2025/10

(45)	Mention of the grant of the patent:
	16.10.2024 Bulletin 2024/42

(21)	Application number: 19800907.8

(22)	Date of filing: 15.11.2019

(51)

International Patent Classification (IPC):

A61P 17/00^(2006.01)
A61K 35/74^(2015.01)
A61K 8/66^(2006.01)
G01N 33/50^(2006.01)

A61P 17/18^(2006.01)
A61K 38/16^(2006.01)
A61K 8/99^(2017.01)

(52)	Cooperative Patent Classification (CPC):
	A61P 17/00; A61P 17/18; A61K 35/74; A61K 38/164; A61K 8/66; A61K 8/99; G01N 33/5044; G01N 33/6893; G01N 2800/7009; A61Q 19/00; A61Q 19/08; A61Q 5/006

(86)	International application number:
	PCT/EP2019/081546

(87)	International publication number:
	WO 2020/099663 (22.05.2020 Gazette 2020/21)

(54)

COMPOSITIONS FOR TREATING OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES AND SKIN AGEING

ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON OXIDATIVEN STRESS-ASSOZIIERTEN HAUTERKRANKUNGEN UND HAUTALTERUNG

COMPOSITIONS POUR LE TRAITEMENT DE MALADIES CUTANÉES ASSOCIÉES AU STRESS OXYDATIF ET DU VIEILLISSEMENT DE LA PEAU

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

16.11.2018 EP 18206646

(43)	Date of publication of application:
	22.09.2021 Bulletin 2021/38

(73)	Proprietor: S-Biomedic NV
	9052 Gent (BE)

(72)	Inventor:
	LOOD, Rolf 224 74 Lund (SE)

(74)	Representative: De Clercq & Partners
	Edgard Gevaertdreef 10a 9830 Sint-Martens-Latem 9830 Sint-Martens-Latem (BE)

(56)

References cited: :

ELSTON MARLEE J ET AL: "Cutibacterium acnes (formerly Proprionibacterium acnes ) and Shoulder Surgery", HAWAI'I JOURNAL OF HEALTH & SOCIAL WELFARE, 1 November 2019 (2019-11-01), United States, pages 3 - 5, XP093019657, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874694/pdf/hjhsw7811_S2_0003.pdf> [retrieved on 20230201]
TILDE ANDERSSON ET AL: "Common skin bacteria protect their host from oxidative stress through secreted antioxidant RoxP", SCIENTIFIC REPORTS, vol. 9, no. 1, 5 March 2019 (2019-03-05), XP055659361, DOI: 10.1038/s41598-019-40471-3
GIZEM ERTÜ RK ET AL: "Highly sensitive detection and quantification of the secreted bacterial benevolence factor RoxP using a capacitive biosensor: A possible early detection system for oxidative skin diseases", 1 March 2018 (2018-03-01), XP055659372, Retrieved from the Internet <URL:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0193754&type=printable> [retrieved on 20200120]
MARIA ALLHORN ET AL: "A novel enzyme with antioxidant capacity produced by the ubiquitous skin colonizer Propionibacterium acnes", SCIENTIFIC REPORTS, vol. 6, no. 1, 2 November 2016 (2016-11-02), XP055659407, DOI: 10.1038/srep36412


	Remarks:
	The complete document including Reference Table(s) and the Sequence Listing(s) can be downloaded from the EPO website


	Remarks:
	The file contains technical information submitted after the application was filed and not included in this specification

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).